Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Angiodynamics Inc (ANGO)

Angiodynamics Inc (ANGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
AngioDynamics Announces Two-Year PRESERVE Trial Data Demonstrating Durable NanoKnife IRE System Outcomes in Intermediate-Risk Prostate Cancer Business Wire - Wed May 13, 8:00AM CDT

Pivotal U.S. Data Show Sustained Oncologic Control and Safety Profile at 24 months Results Presented at AUA 2026

ANGO : 11.92 (-0.33%)
AngioDynamics: Fiscal Q3 Earnings Snapshot AP - Thu Apr 2, 5:11AM CDT

AngioDynamics: Fiscal Q3 Earnings Snapshot

ANGO : 11.92 (-0.33%)
AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability Business Wire - Thu Apr 2, 5:00AM CDT

Med Tech segment delivered its sixth consecutive quarter of double-digit growth Strong adjusted EBITDA Third consecutive quarter the Company raised full year FY 2026...

ANGO : 11.92 (-0.33%)
AngioDynamics Reports Tomorrow But the Guidance Will Matter More Than the Quarter Barchart - Wed Apr 1, 4:02PM CDT

Barchart Research What to Expect from ANGO Earnings ANGO Generated April 1, 2026 Current Price $11.94 EPS Estimate $$-0.11 Consensus Rating Strong Buy Average Move 16.42% AngioDynamics Reports Tomorrow...

ANGO : 11.92 (-0.33%)
AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference Business Wire - Tue Mar 31, 7:00AM CDT

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and...

ANGO : 11.92 (-0.33%)
U.S. Jobs Figures Issued in Short Week Baystreet - Sun Mar 29, 10:36PM CDT

MondayFeatured Earnings Maze Therpautics (NASDAQ:MAZE) (Q4) EPS for loss of 73 cents, compared ...

AYI : 287.59 (+2.30%)
MKC : 47.80 (+1.79%)
FDS : 232.00 (+3.11%)
MSM : 106.50 (+0.49%)
CAG : 13.56 (+1.35%)
NKE : 44.67 (+0.63%)
PRGS : 29.78 (+2.97%)
POET : 14.59 (-1.55%)
LW : 43.76 (+2.22%)
ANGO : 11.92 (-0.33%)
MAZE : 25.78 (+0.12%)
LNN : 109.19 (+0.01%)
AngioDynamics to Report Fiscal 2026 Third Quarter Results on April 2, 2026 Business Wire - Thu Mar 19, 7:00AM CDT

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and...

ANGO : 11.92 (-0.33%)
AngioDynamics to Present at the Leerink Partners Global Healthcare Conference Business Wire - Mon Feb 23, 3:30PM CST

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and...

ANGO : 11.92 (-0.33%)
AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform Business Wire - Thu Feb 19, 7:30AM CST

Growing Clinical Evidence and Physician Adoption Broaden NanoKnife IRE Technology as Treatment Option for Major Solid Tumor Types

ANGO : 11.92 (-0.33%)
AngioDynamics and The PERT Consortium® Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care Business Wire - Thu Feb 5, 7:00AM CST

The ALPHA-PE Research Fund Supports Independent, Physician-Led Studies to Advance Real-World PE Evidence

ANGO : 11.92 (-0.33%)

Barchart Exclusives

Qualcomm Stock Is the Sleeping Giant of the AI Revolution. It’s Starting to Wake Up. Barchart - Sun May 24, 4:41PM CDT
Long weighed down by smartphone market stagnation and the impending loss of Apple as a client, Qualcomm is staging a powerful comeback as it transitions to an aggressive offensive in AI data center inference and physical AI. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.